Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex

Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock

The Food and Drug Administration signed off on Vertex Pharmaceuticals' next-generation triple drug for cystic fibrosis late Friday.

Investors Business Daily

Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?

Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?

Vertex stock was floundering even before Thursday when the company's non-opioid pain drug underperformed expectations in a midstage study.

Investors Business Daily

Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

Vertex stock plummeted Thursday after the company's pain drug proved it's no better than a placebo in patients with lower back and hip pain.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

Vertex Pharmaceuticals reported that its non-opioid drug reduced back pain significantly. But Vertex stock plunged as a placebo showed similar results.

Investors Business Daily

20 innovative breakthroughs that will transform your health

We recognize some of the most staggering, game-changing, life-improving developments of the year.

Decoding 9 Analyst Evaluations For Vertex

During the last three months, 9 analysts shared their evaluations of Vertex (NASDAQ:VERX), revealing diverse outlooks from bullish to bearish.

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals (NASDAQ:VRTX), offering a diverse range of perspectives from bullish to bearish.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?

Is Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Five S&P 500 Stocks On This Elite IBD List Near Buy Points

Five S&P 500 Stocks On This Elite IBD List Near Buy Points

Meta stock and Nvidia peer Broadcom are among among five S&P 500 stocks on IBD Leaderboard that are near buy points.

Investors Business Daily

Stock Market: Three Top Names In Buy Zones, One With Earnings Due

Stock Market: Three Top Names In Buy Zones, One With Earnings Due

The stock market awaits reports from Home Depot, Disney and Cisco Systems. Cisco, Costco and Vertex are in buy zones.

Investors Business Daily

Dow Jones Futures Rise, Bitcoin Tops $82,000 In Trump Rally; Tesla Spikes Amid Big Price Target

Dow Jones Futures Rise, Bitcoin Tops $82,000 In Trump Rally; Tesla Spikes Amid Big Price Target

Futures inched higher while bitcoin topped $82,000 as the Donald Trump rally continues. Nvidia, Meta lead five stocks near buy points.

Investors Business Daily

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review

The stock market surged to highs on Donald Trump's election win. A Fed rate cut and a slew of big earnings reports filled out a busy week.

Investors Business Daily

Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms

Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms

Vertex beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.

Investors Business Daily

Nasdaq Cuts Losses, But Indexes Stay In The Red; Fortinet Triggers New Buy Point, Palo Alto Networks Approaches Breakout Entry (Live Coverage)

Nasdaq Cuts Losses, But Indexes Stay In The Red; Fortinet Triggers New Buy Point, Palo Alto Networks Approaches Breakout Entry (Live Coverage)

Small caps endured a bigger blow as U.S. consumer prices rose 2.4% in September.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Another troubled motor oil company files Chapter 11 bankruptcy

The Houston-based oil refining company files for Chapter 11 bankruptcy seeking to recapitalize its balance sheet or sell its business.

Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?

Vertex Pharmaceuticals has outperformed the Nasdaq over the past year, and analysts remain moderately bullish about the stock's prospects.

Are Wall Street Analysts Bullish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market in 2024 but Wall Street analysts remain cautiously bullish about the stock's potential.

Investors Business Daily

Vertex Slumps As Guidance Hike — Featuring The Gene-Editing Launch — Fails To Erase Losses

Vertex stock fell late Thursday after the company reported light sales and wide losses. But the company boosted its outlook for the year.

Get all your
news in one place.

100’s of premium titles.
One news app.

The British watch brands to know now: from intriguing innovators to heritage revivals

British watch brands are in the ascendant – discover some of the most exciting names and their timepieces

Is Vertex Stock Outperforming the S&P 500?

Vertex has outperformed the S&P 500 over the past year, and analysts are moderately bullish on the stock.

Investors Business Daily

Dow Jones Futures Fall As Growth Fears Mount; 7 Stocks Near Buy Points

The stock market was mixed Monday, but once again closed strong. Nvidia jumped while Meta and Spotify are stocks near buy points.

Investors Business Daily

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

Investors Business Daily

Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers

The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.

Investors Business Daily

Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares

Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.

Vertex 2024 - our best bits and some surprises

We had a blast at Vertex 2024, here are the highlights.

1 2 3 4 5

People

Patrick Walravens

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

243,639 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play